PMID- 15363505 OWN - NLM STAT- MEDLINE DCOM- 20050125 LR - 20181130 IS - 0378-5173 (Print) IS - 0378-5173 (Linking) VI - 283 IP - 1-2 DP - 2004 Sep 28 TI - Effect of plasticization on heparin release from biodegradable matrices. PG - 89-96 AB - Heparin-loaded polymer films of poly-L-lactide (PLLA) and poly-L-lactide-co-glycolide (PLLGA) as well as poly-DL-lactide-co-glycolide (PLGA) were produced. A plasticizer, PEG, was added to the polymers. It was found that the release profile in general consisted of a burst effect, a diffusion-controlled phase and a degradation-controlled phase. The plasticizer accelerated the onset of degradation in all cases, but its effect on the release profile differed significantly depending on the polymer. The plasticizer depressed the burst effect for PLLA, and accelerated the kinetics of the diffusion-controlled phase. For the PLLGA 80/20, however, the plasticizer had no significant effect on the release profile or kinetics. We explain these observations in terms of hydrophilicity and crystallinity effects. FAU - Tan, L P AU - Tan LP AD - School of Materials Engineering, Nanyang Technological University, N4.1-1-30 Nanyang Avenue, Singapore 639798, Singapore. FAU - Venkatraman, S S AU - Venkatraman SS FAU - Sung, P F AU - Sung PF FAU - Wang, X T AU - Wang XT LA - eng PT - Journal Article PL - Netherlands TA - Int J Pharm JT - International journal of pharmaceutics JID - 7804127 RN - 0 (Anticoagulants) RN - 0 (Biocompatible Materials) RN - 0 (Plasticizers) RN - 0 (Polyesters) RN - 0 (Polymers) RN - 1SIA8062RS (Polylactic Acid-Polyglycolic Acid Copolymer) RN - 26009-03-0 (Polyglycolic Acid) RN - 33X04XA5AT (Lactic Acid) RN - 459TN2L5F5 (poly(lactide)) RN - 9005-49-6 (Heparin) SB - IM MH - *Absorbable Implants MH - Anticoagulants/*administration & dosage MH - *Biocompatible Materials MH - Heparin/*administration & dosage MH - Lactic Acid MH - *Plasticizers MH - Polyesters MH - Polyglycolic Acid MH - Polylactic Acid-Polyglycolic Acid Copolymer MH - Polymers MH - Stents MH - *Technology, Pharmaceutical EDAT- 2004/09/15 05:00 MHDA- 2005/01/26 09:00 CRDT- 2004/09/15 05:00 PHST- 2004/03/18 00:00 [received] PHST- 2004/06/11 00:00 [revised] PHST- 2004/06/25 00:00 [accepted] PHST- 2004/09/15 05:00 [pubmed] PHST- 2005/01/26 09:00 [medline] PHST- 2004/09/15 05:00 [entrez] AID - S0378-5173(04)00420-X [pii] AID - 10.1016/j.ijpharm.2004.06.022 [doi] PST - ppublish SO - Int J Pharm. 2004 Sep 28;283(1-2):89-96. doi: 10.1016/j.ijpharm.2004.06.022.